Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Liraglutide to Overweight Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (MDI) With Inadequate Glycaemic Control

NCT02113332 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT02113332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02113332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Liraglutide to Overweight Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (MDI) With Inadequate Glycaemic Control
Lead sponsor
Vastra Gotaland Region
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2014
Enrollment
124 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus